Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on: January 02,2024 9

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on:January 02,2024 9

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024 16

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024 16

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on: March 12,2024 10

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on:March 12,2024 10

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri

Updated on: March 06,2024 13

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri

Updated on:March 06,2024 13

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on: May 13,2024 6

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on:May 13,2024 6

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on: March 30,2024 0

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on:March 30,2024 0

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on: March 01,2024 16

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on:March 01,2024 16

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on: January 30,2024 18

Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on:January 30,2024 18

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on: January 12,2024 8

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on:January 12,2024 8

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on: March 08,2024 19

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on:March 08,2024 19

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on: November 30,2024 0

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on:November 30,2024 0